Jan 04,2023

Lilly to Participate in the J.P. Morgan Healthcare Conference

Eli Lilly and Company (NYSE: LLY) will attend the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2023. David A. Ricks, Lilly's chair and CEO, will participate in a fireside chat at 6:45 p.m. Eastern time.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 02,2023

Fruit Street Health Surpasses 44,000 Participants Enrolled Into Its CDC-Recognized Diabetes Prevention Program

Fruit Street Health, a CDC-recognized distance learning provider of the National Diabetes Prevention Program, today announced surpassing more than 44,000 participants enrolled into its diabetes prevention program since launching its program in late 2017. Fruit Street’s diabetes prevention program is a twelve month program designed to help people with prediabetes reduce their risk for Type 2 diabetes by losing 5-7% of their weight through diet and lifestyle changes. The program consists of 26 one-hour long classes between a dietitian and a group of 30 other participants delivered via Zoom.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Jan 03,2023

Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:15pm Eastern Time (5:15pm Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 03,2023

Dexcom to Present at 41st Annual J.P. Morgan Healthcare Conference

DexCom, Inc. today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 41st annual J.P. Morgan Healthcare Conference on January 9, 2023. The live presentation is scheduled to begin at approximately 2:15 PM EST and will be concurrently webcast.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 04,2023

Know Labs wins new glucose monitoring patent

Know Labs announced today that it received a new patent equating its diagnostic technology to the current glucose monitoring standard. Seattle-based Know Labs develops the Bio-RFID technology. It uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. It integrate into wearable, mobile or bench-top form factors. The first application of the technology comes in the form of a non-invasive glucose monitor.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 05,2023

Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc., a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it had made equity grants to new employees under its 2019 Inducement Plan in accordance with NYSE American Company Guide Section 711(a).

View Analyst & Ambassador Comments
Go to original news
Jan 05,2023

BIOCORP: 2023 Financial Calendar

BIOCORP presents its financial reporting schedule for 2023. The company announced to release its 2022 full-year results on Thursday, April 6th, 2023, before the market opening.

View Analyst & Ambassador Comments
Go to original news
Jan 09,2023

Vida Health Makes Two Additions to Executive Leadership Team

Virtual cardiometabolic care leader Vida Health today announced the additions of Elaine Divelbliss and Andrew Webb to its executive leadership team. Divelbliss as Chief People Officer & General Counsel and Webb as Chief Financial Officer.

View Analyst & Ambassador Comments
Go to original news
Jan 09,2023 TOP STORY

Omada Health Partners with Intermountain Healthcare and Castell to Establish Integrated Virtual Care Option for Diabetes Management and Prevention

Omada Health, a virtual, integrated chronic care healthcare provider, and Castell, Intermountain Healthcare’s value-based care subsidiary, have entered into a partnership that expands the access of Omada’s Diabetes Prevention Program and Diabetes Program to patients and caregivers receiving care from Intermountain Healthcare’s primary care providers within its Utah Medical Group. Castell will help to target and enroll eligible patients through their existing care pathways. Patients who have, or are at risk for, diabetes will be proactively contacted by Castell care coordinators and Intermountain providers to give them the option to enroll into the appropriate Omada program.

COLLABORATION PARTNERSHIP

#institution

#virtual care

#coaching

View Analyst & Ambassador Comments
Go to original news
Jan 09,2023

Hybrid care provider Carbon Health announces more layoffs

Virtual primary and urgent care provider Carbon Health announced another round of layoffs, noting the company is letting go of more than 200 people. The company let go of over 200 people in its second round of layoffs in the past year and plans to shift its focus to its primary care and urgent care services.

#virtual care

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES